Cargando…

Treating chronic urticaria refractory to H1-antihistamines in Russia: data from the AWARE study

INTRODUCTION: Data on burden and treatment outcomes of chronic spontaneous urticaria (CSU) in Russia are limited. Poor adherence to recommended treatments can lead to suboptimal management of CSU patients. AIM: To understand disease burden, treatment algorithms, and outcomes of CSU in the Russian co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danilycheva, Inna, Emelyanov, Alexander, Meshkova, Raisa, Ukhanova, Olga, Abdrakhmanov, Azat, Litvin, Loliana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326929/ https://www.ncbi.nlm.nih.gov/pubmed/35950113 http://dx.doi.org/10.5114/ada.2022.117556

Ejemplares similares

Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
por: Durda, J., et al.
Publicado: (2017)

Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines
por: Kim, Mi-Ae, et al.
Publicado: (2023)

Fenebrutinib in H(1) antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial
por: Metz, Martin, et al.
Publicado: (2021)

Features of Antihistamine-Resistant Chronic Urticaria and Chronic Urticaria During Exacerbation
por: Huilan, Zhu, et al.
Publicado: (2015)

Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H(1)-Antihistamines in Asia, Middle-East and Africa: Results from the AWARE-AMAC study
por: Chu, Chia-Yu, et al.
Publicado: (2020)

CSACI position statement: Newer generation H(1)-antihistamines are safer than first-generation H(1)-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria
por: Fein, Michael N., et al.
Publicado: (2019)

Bepotastine-induced urticaria, cross-reactive with other antihistamines
por: Kang, Ju Wan, et al.
Publicado: (2016)

The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria
por: Choi, Jeong-Hee, et al.
Publicado: (2020)

The influence of hepatitis C virus infection on H1 antihistamine treatment in urticaria patients
por: Dinu, Lucia, et al.
Publicado: (2014)

Drug eruption by antihistamine mistaken for chronic urticaria in a child
por: Lee, Gun Moo, et al.
Publicado: (2019)

Pathobiology of Second-Generation Antihistamines Related to Sleep in Urticaria Patients
por: Mann, Caroline, et al.
Publicado: (2022)

Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study
por: Ulambayar, Bastsetseg, et al.
Publicado: (2019)

High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
por: Madsen, Hanne, et al.
Publicado: (2021)

Evidence Gaps in Clinical Trials of Pharmacologic Treatment for H1-Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Future Perspectives
por: Nochaiwong, Surapon, et al.
Publicado: (2022)

Bilastine: A New Nonsedating Oral H1 Antihistamine for Treatment of Allergic Rhinoconjunctivitis and Urticaria
por: Wolthers, Ole D.
Publicado: (2013)

Autologous Serum Therapy in Chronic Urticaria: A Promising Complement to Antihistamines
por: Debbarman, Panchami, et al.
Publicado: (2014)

Comparative efficacy of non-sedating antihistamine updosing in patients with chronic urticaria
por: Sánchez-Borges, Mario, et al.
Publicado: (2014)

Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia
por: Recto, Marysia Tiongco, et al.
Publicado: (2017)

Corrigendum: High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
Publicado: (2022)

Awareness of Family Physicians Towards Antihistamines
por: Zeerak, Sumaya, et al.
Publicado: (2019)

The Efficacy of a Two-Fold Increase of H1-Antihistamine in the Treatment of Chronic Urticaria - the Vietnamese Experience
por: Thi, Huyen Tran, et al.
Publicado: (2019)

Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review
por: Hsieh, Chang-Yu, et al.
Publicado: (2021)

Altered Gut Microbiota in H1-Antihistamine-Resistant Chronic Spontaneous Urticaria Associates With Systemic Inflammation
por: Song, Yao, et al.
Publicado: (2022)

Autologous Whole Blood Injection for the Treatment of Antihistamine-Resistant Chronic Spontaneous Urticaria
por: You, Hyang-Suk, et al.
Publicado: (2015)

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
por: Wang, Xue Yan, et al.
Publicado: (2016)

Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria
por: van den Elzen, Mignon T., et al.
Publicado: (2017)

Autologous serum therapy reduces the symptoms and antihistamine burden in patients with chronic urticaria
por: Mohammed, Jinan Q.
Publicado: (2023)

Variations of Thiol–Disulfide Homeostasis Parameters after Treatment with H1-Antihistamines in Patients with Chronic Spontaneous Urticaria
por: Matei, Clara, et al.
Publicado: (2021)

Comparing azathioprine with cyclosporine in the treatment of antihistamine refractory chronic spontaneous urticaria: A randomized prospective active-controlled non-inferiority study()
por: Pathania, Yashdeep Singh, et al.
Publicado: (2019)

269 Refractory Chronic Urticaria Treated with Omalizumab
por: Saenz, Martinez, et al.
Publicado: (2012)

Urticaria relapse after mRNA COVID‐19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single‐center experience
por: Picone, Vincenzo, et al.
Publicado: (2022)

H1 antihistamines and driving
por: Florin-Dan, Popescu
Publicado: (2008)

Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review
por: Di Lorenzo, Gabriele, et al.
Publicado: (2008)

Compound glycyrrhizin combined with antihistamines for chronic urticaria: A protocol for systematic review and meta analysis
por: Cao, Wei, et al.
Publicado: (2020)

H(1)-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects – A Retrospective Survey Study
por: Weller, Karsten, et al.
Publicado: (2011)

Up-dosing of non-sedating antihistamines in chronic urticaria: Need for well-designed clinical trials in India
por: Patil, Anant D.
Publicado: (2014)

A protocol for the development and internal validation of a model to predict clinical response to antihistamines in urticaria patients
por: Sanchez, Jorge, et al.
Publicado: (2020)

The effect of inflammatory diseases associated with opportunistic urogenital infection on the hormonal function of the female reproductive system
por: Azat Rasimovich, Abdrakhmanov, et al.
Publicado: (2018)

Night-time sedating H(1)-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial
por: Staevska, M, et al.
Publicado: (2014)

Efficacy of NB-UVB as Add-on Therapy to Antihistamine in the Treatment of Chronic Urticaria: A Systematic Review and Meta-analysis
por: Chen, Jiaoquan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e0l8pd5an1cr2c6r080u19d3ci